MARKET

MOTS

MOTS

MOTUS GI HOLDING
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9911
+0.0070
+0.71%
After Hours: 1.010 +0.019 +1.91% 19:22 04/22 EDT
OPEN
1.000
PREV CLOSE
0.9841
HIGH
1.020
LOW
0.9601
VOLUME
587.04K
TURNOVER
--
52 WEEK HIGH
2.740
52 WEEK LOW
0.6800
MARKET CAP
46.33M
P/E (TTM)
-1.6058
1D
5D
1M
3M
1Y
5Y
Colliers Securities Thinks Motus Gi Holdings’ Stock is Going to Recover
Colliers Securities analyst Kyle Bauser reiterated a Buy rating on Motus Gi Holdings (MOTS) today and set a price target of $2.50. The company's shares
SmarterAnalyst · 1d ago
Motus Gi Holdings (MOTS) Received its Third Buy in a Row
After Colliers Securities and Oppenheimer gave Motus Gi Holdings (NASDAQ: MOTS) a Buy rating last month, the company received another Buy, this time from
SmarterAnalyst · 04/07 10:16
Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy
Benzinga · 04/06 13:57
Motus GI Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy
GlobeNewswire · 04/06 13:00
Motus GI shares rise on Pure-Vu System 510k application submission
Motus GI Holdings (MOTS) shares up more than 3% premarket after announcing that it has submitted a 510(k) application to the U.S. FDA for a version of its Pure-Vu System.The application is for
Seekingalpha · 04/06 12:37
ILMN, CARA among premarket gainers
Brooklyn Immuno Therapeutics (BTX) +77%.Scienjoy Holding (SJ) +37% on strategic alliance with Snipp.Weidai (WEI) +26%.Elite Education Group International (EEIQ) +16%.Phunware (PHUN) +12%. as board authorizes bitcoin purchases for Blockchain Ecosystem Launc...
Seekingalpha · 04/06 12:33
BRIEF-Motus GI Submits 510(K) Application To FDA For The Pure-Vu System For Upper GI Endoscopy
reuters.com · 04/06 12:12
Motus GI Submits 510(k) Application To FDA For Pure-Vu System For Upper GI Endoscopy
 Motus GI Holdings, Inc., (NASDAQ:MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency
Benzinga · 04/06 12:01
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MOTS. Analyze the recent business situations of MOTUS GI HOLDING through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MOTS stock price target is 2.417 with a high estimate of 2.750 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 41
Institutional Holdings: 11.62M
% Owned: 24.86%
Shares Outstanding: 46.75M
TypeInstitutionsShares
Increased
5
544.23K
New
2
13.89K
Decreased
4
2.58M
Sold Out
6
108.61K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.76%
Healthcare Equipment & Supplies
+0.51%
Key Executives
Chairman/Independent Director
David Hochman
President/Chief Operating Officer/Director
Mark Pomeranz
Chief Executive Officer/Director
Timothy Moran
Chief Financial Officer
Andrew Taylor
Independent Director
Shervin Korangy
Independent Director
Samuel Nussbaum
Independent Director
Gary Pruden
Independent Director
Darren Sherman
No Data
About MOTS
Motus GI Holdings, Inc. is a medical technology company that operates along with its subsidiaries Motus, Ltd. and Motus, Inc. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure. The Pure-Vu System also helps in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon This device fits standard colonoscopes, allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa.

Webull offers kinds of Motus GI Holdings Inc stock information, including NASDAQ:MOTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MOTS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MOTS stock methods without spending real money on the virtual paper trading platform.